108 related articles for article (PubMed ID: 37254544)
21.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
22. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
23. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
24. UBR5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21.
Ji SQ; Zhang YX; Yang BH
Pharmazie; 2017 Jul; 72(7):408-413. PubMed ID: 29441938
[TBL] [Abstract][Full Text] [Related]
25. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
26. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of UBR5 promotes tumor growth in gallbladder cancer via PTEN/PI3K/Akt signal pathway.
Zhang Z; Zheng X; Li J; Duan J; Cui L; Yang L; Zhang L; Zhang Q; Wang X
J Cell Biochem; 2019 Jul; 120(7):11517-11524. PubMed ID: 30775814
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
29. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
30. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
Bethard JR; Zheng H; Roberts L; Eblen ST
J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
[TBL] [Abstract][Full Text] [Related]
31. Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
Panfil AR; Al-Saleem J; Howard CM; Shkriabai N; Kvaratskhelia M; Green PL
Front Microbiol; 2018; 9():80. PubMed ID: 29441057
[TBL] [Abstract][Full Text] [Related]
32. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
33. The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia.
Shearer RF; Frikstad KM; McKenna J; McCloy RA; Deng N; Burgess A; Stokke T; Patzke S; Saunders DN
Mol Biol Cell; 2018 Jul; 29(13):1542-1554. PubMed ID: 29742019
[TBL] [Abstract][Full Text] [Related]
34. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
35. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.
Song M; Wang C; Wang H; Zhang T; Li J; Benezra R; Chouchane L; Sun YH; Cui XG; Ma X
Oncoimmunology; 2020; 9(1):1746148. PubMed ID: 32363114
[TBL] [Abstract][Full Text] [Related]
36. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
Swenson SA; Gilbreath TJ; Vahle H; Hynes-Smith RW; Graham JH; Law HC; Amador C; Woods NT; Green MR; Buckley SM
Blood; 2020 Jul; 136(3):299-312. PubMed ID: 32325489
[TBL] [Abstract][Full Text] [Related]
37. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
38. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
39. A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective.
Bao H; Luo Y; Ding G; Fu Z
J Oncol; 2022; 2022():3982539. PubMed ID: 35578600
[TBL] [Abstract][Full Text] [Related]
40. Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery.
Wang M; Ma X; Wang G; Song Y; Zhang M; Mai Z; Zhou B; Ye Y; Xia W
Cell Mol Biol Lett; 2022 Oct; 27(1):92. PubMed ID: 36224534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
